- Investing Ideas
- Global Pharmaceuticals & Biotech Spotless Management
Global Pharmaceuticals & Biotech Spotless Management
Results
7
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
7 companies
AstraZeneca
Market Cap: UK£195.9b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£126.28
7D
-5.4%
1Y
22.5%
Gilead Sciences
Market Cap: US$163.5b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$136.30
7D
1.1%
1Y
25.3%
Chugai Pharmaceutical
Market Cap: JP¥11.9t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥7,241.00
7D
-1.6%
1Y
4.6%
Orion Oyj
Market Cap: €9.7b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€68.75
7D
-2.6%
1Y
4.1%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥55.8b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥124.10
7D
2.0%
1Y
25.3%
Xiamen Amoytop Biotech
Market Cap: CN¥24.6b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥60.29
7D
9.9%
1Y
-21.4%
PharmaResearch
Market Cap: ₩3.5t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩336,500.00
7D
8.9%
1Y
-41.8%